Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber.
A bacterial containment chamber was used to evaluate the peritoneal cellular response to Bacteroides fragilis during intraperitoneal challenge. This containment system was also used to determine the fate of bacteria within the peritoneal cavities of animals immunized, either actively or through adoptive transfer of cells or cell lysates, with the capsular polysaccharide of B. fragilis. This system demonstrated that the dominant cell types in the peritoneal cavities within 48 h of implantation of the containment chambers containing B. fragilis were neutrophils and macrophages. However, the early cellular response in immunized animals included an increase in the lymphocyte population within 4 h of challenge which was not detected in naive animals. In immunized animals, a later dramatic increase in the lymphocyte population at approximately 4 to 6 days following implantation of the containment chambers occurred. This increase in the lymphocyte population in immunized animals coincided with a decline in the viable bacterial counts within the chambers from 10(8) to 10(9) CFU/ml to less than 10(2) CFU/ml. A similar decline was not seen in naive animals challenged in the same manner. Killing of B. fragilis within containment chambers occurred when spleen cells, T cells, or lysates of T cells from actively immunized animals were passively transferred to naive recipient animals. It was shown that the factor responsible for bacterial killing was not antibody mediated, since bacteria contained within dialysis sacs with an exclusion of 50 kilodaltons were still killed in this model. Moreover, removal of T cells from adoptively transferred cell populations before transfer abrogated the decline in viable bacterial populations. The postulated mechanisms by which this bacterial killing occurred are discussed.
Onderdonk
A B
AB
Infectious Diseases Research Laboratory, Tufts University School of Medicine, Boston, Massachusetts.
Cisneros
R L
RL
Crabb
J H
JH
Finberg
R W
RW
Kasper
D L
DL
D000818:Animals; D000907:Antibodies, Bacterial / Q000502:physiology; D001441:Bacteroides fragilis / Q000254:growth & development* / Q000276:immunology; D015169:Colony Count, Microbial; D015194:Diffusion Chambers, Culture; D007110:Immunity, Active; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007958:Leukocyte Count; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008851:Micropore Filters; D010529:Peritoneal Cavity / Q000276:immunology / Q000382:microbiology*; D010530:Peritoneal Dialysis; D010587:Phagocytosis
D000907:Antibodies, Bacterial